Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine vs pregabalin in painful diabetic neuropathy
IRCT20180814040795N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in diabetic polyneuropathy (DPN) and diabetic neuropathy comparing N-acetylcysteine with Pregabalin (2 arms). Primary endpoint: Change in oxidative stress biomarkers. Started Aug 2018; status: completed.
02
Drugs
acetylcysteinepregabalin
03
Conditions
diabetic polyneuropathy (DPN)diabetic neuropathy
Beyond the preview
Go deeper on IRCT20180814040795N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180814040795N2.